Wei Zhang

ORCID: 0000-0003-2049-3810
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Transplantation Techniques and Outcomes
  • Transplantation: Methods and Outcomes
  • Liver Disease and Transplantation
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Biosimilars and Bioanalytical Methods
  • Antimicrobial Resistance in Staphylococcus
  • Helicobacter pylori-related gastroenterology studies
  • Long-Term Effects of COVID-19
  • Heat shock proteins research
  • Food composition and properties
  • Urban Transport and Accessibility
  • Biochemical and Molecular Research
  • HIV/AIDS Research and Interventions
  • Impact of Light on Environment and Health
  • PI3K/AKT/mTOR signaling in cancer
  • Inflammatory Biomarkers in Disease Prognosis
  • Microbial Metabolites in Food Biotechnology
  • Human Mobility and Location-Based Analysis
  • Viral gastroenteritis research and epidemiology
  • Probiotics and Fermented Foods
  • Organ Donation and Transplantation
  • COVID-19 Impact on Reproduction
  • Protein Kinase Regulation and GTPase Signaling
  • Hepatocellular Carcinoma Treatment and Prognosis

Zhejiang University
2007-2025

Hangzhou DAC Biotech (China)
2025

First Affiliated Hospital Zhejiang University
2020-2024

ZheJiang Institute For Food and Drug Control
2023

Hangzhou First People's Hospital
2021

Boehringer Ingelheim (United States)
2017

Sir Run Run Shaw Hospital
2007

To evaluate the response and safety of an inactivated vaccine (Sinovac Life Sciences Co., Ltd., Beijing, China) for coronavirus disease 2019 (COVID-19) in liver transplant (LTx) recipients from China.Thirty-five post LTx First Affiliated Hospital Zhejiang University School Medicine who received June to October 2021 were screened. Information regarding side effects clinical data collected.Thirty-five enrolled, with a mean age 46 years, most patients male (30, 85.71%). All participants had...

10.2147/idr.s359919 article EN cc-by-nc Infection and Drug Resistance 2022-05-01
Weihao Li Hubert P. J. van der Doef Barbara E. Wildhaber Paolo Marra M. Bravi and 95 more D. Pinelli Julia Minetto Marcelo Dip Sergio Sierre Martín de Santibañes Victoria Ardiles J Uno Winita Hardikar Sue Bates Lynette Goh Denise Aldrian Jonathan Seisenbacher Georg F. Vogel João Seda Neto Eduardo A. Fonseca Carolina Magalhães Costa Cristina Targa Ferreira Luiza Salgado Nader Marco Farina Khaled Dajani Alessandro Parente David L. Bigam Ting-Bo Liang Xueli Bai Wei Zhang Lucie Gonsorčíková Jiří Froněk Šimon Bohuš Stéphanie Franchi‐Abella Emmanuel Gonzalès Florent Guérin Norman Junge Ulrich Baumann Nicolas Richter Steffen Hartleif Ekkehard Sturm Muthukumarassamy Rajakannu Kumar Palaniappan Mohamed Rela Arti Pawaria Haritha Rajakrishnan S Sudhindran Mukesh Kumar Shaleen Agarwal Subhash Gupta Sonal Asthana Vaishnavi Bandewar Karthik Raichurkar Marco Spada Lidia Monti Tommaso Alterio Yusuke Yanagi Hajime Uchida Ryuji Komine Helen Evans Peter Carr‐Boyd David Duncan Marek Stefanowicz Julita Latka-Grot Adam Koleśnik Dieter C. Bröering Dimitri Aristotle Raptis Kris Ann Hervera Marquez Vidyadhar Padmakar Mali Marion M. Aw Marisa Beretta Francisca van der Schyff Jesús Quintero-Bernabeu María Mercadal‐Hally Mauricio Larrarte King Ane Miren Andrés F Hernández E. Frauca Thomas Casswall Carl Jorns Martin Delle Girish Gupte Khalid Sharif Simon P. McGuirk Riccardo Superina Juan C. Caicedo Catalina Jaramillo Leandra Bitterfeld Zachary J. Kastenberg Amit A. Shah Bryanna N. Domenick Michael R. Acord George Mazariegos Kyle Soltys Joseph DiNorcia Swanti Antala Sander Florman Bettina M. Buchholz Uta Herden Lutz Fischer

Hepatic artery complications (HACs), such as a thrombosis or stenosis, are serious causes of morbidity and mortality after paediatric liver transplantation (LT). This study will investigate the incidence, current management practices outcomes in patients with HAC LT, including early late complications.

10.1136/bmjopen-2023-081933 article EN cc-by-nc BMJ Open 2024-06-01

We analyzed the characteristics, risk factors, outcomes, and post-coronavirus disease 2019 (COVID-19) symptoms in liver transplant recipients China's late 2022 COVID-19 wave. Recipients with were enrolled from December 1, 2022, to January 31, 2023, followed up until May 2023. Baseline characteristic data collected. A total of 930 included, a vaccination rate (non-mRNA) 40.0%. Among 726 (78.1%) COVID-19, 641 (88.3%) patients treated at home, 81 (11.2%) required hospitalization general wards,...

10.1016/j.ajt.2023.09.022 article EN cc-by-nc-nd American Journal of Transplantation 2023-10-18

Background: VERxVE data showed non-inferior virologic efficacy with extended release nevirapine (NVP-XR) dosed 400 mg once daily (QD) versus immediate (NVP-IR) 200 twice in a double-blind, non-inferiority study treatment-naïve HIV-1-positive patients.Objective: To the pharmacokinetics (PK) of NVP formulations and identify possible associations demographic factors.Methods: Patients viral load ≥1000 copies/mL CD4+ count > 50– <400 cells/mm3 (males) >50– <250 (females) at screening received...

10.1080/15284336.2017.1386811 article EN HIV Clinical Trials 2017-11-02

Abstract Background Although criteria for liver transplantation, such as the Milan and Hangzhou experiences, have become popular, to guide adjuvant therapy patients with hepatocellular carcinoma after transplantation are lacking. Methods We collected data from all consecutive 2012 2019 at three centers in China retrospectively. Univariate multivariate analyses were used analyze preoperative parameters, demographic clinical data. Using obtained our center, calibration curves concordance...

10.21203/rs.3.rs-32861/v1 preprint EN cc-by Research Square (Research Square) 2020-06-10

Hu7691 represents a novel Pan-Akt kinase inhibitor, demonstrating excellent selectivity towards non-AGC families and pronounced inhibitory effects on the proliferation of multiple tumor cell lines. However, there is currently notable absence in vivo toxicological research evidence concerning Hu7691. This study first investigation into 14-day repeated-dose toxicity male female Sprague Dawley (SD) rats. Male rats were administered daily doses 12.5, 50, 100, 150 mg/kg/day, while received 25, 75...

10.3390/toxics11110880 article EN cc-by Toxics 2023-10-26

Abstract Purpose To present our experience of using the pediatric donor superior mesenteric artery (SMA) as interpositioning vessel to reconstruct hepatic in deceased liver transplantation. Methods Pediatric patients who received livers from December 2019 June 2021 were enrolled. Results A total 43 recipients during study period. Thirty-four (79.1%) donors had normal anatomy, while nine (20.9%) showed variant anatomies. The SMAs interposed latter eight cases. anastomosis between distal SMA...

10.21203/rs.3.rs-2078931/v1 preprint EN cc-by Research Square (Research Square) 2022-09-22

Infection is a significant risk factor that impacts for perioperative morbidity and mortality in liver transplantation (LTx) patients difficult to evaluate quantitatively the early posttransplantation period. Thus, biomarker assess of infection prognosis recipient highly desirable.A total 128 consecutive with end-stage diseases undergoing LTx between January 1, 2020 December 31, 2021, at First Affiliated Hospital Zhejiang University School Medicine, were screened retrospectively. Graft...

10.1111/tid.14002 article EN Transplant Infectious Disease 2022-12-22

The research is to build a cloud-base data analysis system with the UniMelb Research Cloud study lifestyle among suburbs within Inner Melbourne. Beyond academic purpose, can be applied for business measures, such as consumer behavior of Australians. To better understand Australians' lifestyles, analytic requires features crawling from twitter, storing information, and analyzing correlations between trendy topics user 's demography. objective project prove feasibility reliability by verifying...

10.1109/cbase57816.2022.00030 article EN 2022-09-01
Coming Soon ...